Live mucosal vaccination stimulates potent protection via varied CD4+ and CD8+ T cell subsets against wild-type Brucella melitensis 16M challenge
Re-emerging zoonotic pathogen Brucella spp. continues to impact developing countries and persists in expanding populations of wildlife species in the US, constantly threatening infection of our domestic herds. The development of improved animal and human vaccines remains a priority. In this study, i...
Main Authors: | Zakia I. Goodwin, Xinghong Yang, Carol Hoffman, David W. Pascual |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.995327/full |
Similar Items
-
Parenteral Vaccination with a Live <i>Brucella melitensis</i> Mutant Protects against Wild-Type <i>B. melitensis</i> 16M Challenge
by: Xinghong Yang, et al.
Published: (2024-01-01) -
Mucosal Vaccination Primes NK Cell-Dependent Development of CD8+ T Cells Against Pulmonary Brucella Infection
by: Ella Bhagyaraj, et al.
Published: (2021-07-01) -
Activation of mucosal immunity as a novel therapeutic strategy for combating brucellosis
by: David W. Pascual, et al.
Published: (2022-12-01) -
Proteínas inmunodominantes de Brucella Melitensis evaluadas por Western Blot
by: Elizabeth Anaya, et al.
Published: (1997-01-01) -
Antibiotic Susceptibility of Brucella Melitensis in Markazi Province (2014)
by: Ali Asghar Farazi, et al.
Published: (2016-04-01)